Until well-designed clinical trials are conducted, BPC-157 should be considered investigational, and its use approached with caution
It is not that the science fails to support their therapeutic potential
Conclusion The debate between BPC-157 and TB-500 is ultimately a debate between two halves of the same biological process
It transfers risk to the patient
Conditions BPC-157 Treats Tendon injuries : Rotator cuff tears, Achilles tendinitis, tennis elbow Muscle tears : Hamstring, quadriceps, shoulder Joint pain : Knee, hip, shoulder inflammation Gut health : Leaky gut, IBS, stress-related digestive issues Important : BPC-157 isnt a magic bullet